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Abstract. – OBJECTIVE: Childhood ob-
structive sleep disordered breathing (SDB) is 
a sleep-related upper airway obstruction that 
degrades sleep quality, ventilation and/or ox-
ygenation; obstructive sleep apnea syndrome 
(OSAS) is one of the most common causes of 
SDB in children. The aim of this review is to 
evaluate the role of the anesthesiologist in pe-
diatric OSAS.
MATERIALS AND METHODS: A literature re-
view has been performed on the following top-
ics: clinical aspects of pediatric OSAS, preop-
erative investigations including questionnaires, 
clinical parameters, laboratory polysomnogra-
phy and home sleep apnea testing, anesthesio-
logic preoperative management, anesthesiolog-
ic perioperative management, anesthesiologic 
postoperative management including postoper-
ative analgesia, postoperative nausea and vom-
iting (PONV), and post‐tonsillectomy bleeding.
RESULTS: OSAS in children is a distinct dis-
order from the condition that occurs in adults; 
adenoidectomy and tonsillectomy are the first 
line of therapy in these patients. Even if these 
surgical procedures are frequently performed, 
they represent a great challenge for surgeons 
and anesthesiologists and are associated with 
a substantially increased risk of morbidity and 
mortality.
CONCLUSIONS: The role of the anesthesiolo-
gist is pediatric OSAS is crucial before, during 
and after surgery, as pediatric patients are at 
higher risk of preoperative, perioperative and 
postoperative adverse events including airway 
obstruction, PONV, and bleeding.
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Introduction
Childhood obstructive sleep-disordered breath-
ing (SDB) is a sleep-related upper airway obstruc-
tion that degrades sleep quality, ventilation and/or 
oxygenation. Obstructive sleep apnea syndrome 
(OSAS) is one of the most common causes of 
SDB in children. Prevalence of SDB and OSAS in 
children is respectively 12% and 3%1.
Adenoidectomy and tonsillectomy are widely 
used surgical procedures in pediatric patients 
with SDB and in many cases represent the first 
line of therapy. After surgery, the resolution of 
OSAS occurs in nearly 82% of pediatric patients2. 
Furthermore, the effects of adenoidectomy and 
tonsillectomy include improvement of behavior, 
quality of life measures, neurocognitive function-
ing and academic performance. 
Even if these surgical procedures are frequently 
performed, they represent a great challenge for 
surgeons and anesthesiologists and are associated 
with a substantially increased risk of morbidity 
and mortality3. In a study on malpractice claims 
after tonsillectomy Morris et al4 found that chil-
dren had more fatal respiratory failure events 
after tonsillectomy and adenoidectomy than adults 
(Table I). 
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In this review, we examine the most recent 
literature on pediatric OSAS and discuss the role 
of the anesthesiologist before, during and after 
adenoidectomy and tonsillectomy surgery.
Materials and Methods
A literature review has been performed on 
articles retrieved from PubMed and Scopus from 
the last 30 years on the following topics: clinical 
aspects of pediatric OSAS, preoperative inves-
tigations including questionnaires, clinical pa-
rameters and laboratory polysomnography and 
home sleep apnea testing, anesthesiologic preop-
erative management, anesthesiologic periopera-
tive management, anesthesiologic postoperative 
management including postoperative analgesia, 
postoperative nausea and vomiting (PONV) and 
post-tonsillectomy bleeding.
Results
Clinical aspects of pediatric OSAS
OSAS is defined by the American Thoracic 
Society5 as “a disorder of breathing during sleep 
characterized by prolonged partial upper airway 
obstruction and/or intermittent complete ob-
struction (obstructive apnea) that disrupts nor-
mal ventilation during sleep and normal sleep 
patterns”.
OSAS in children is a distinct disorder from 
the condition that occurs in adults, such that the 
clinical manifestations, diagnostic criteria and, 
more important, treatment approaches need to be 
considered in an age-specific manner. 
OSAS affects 1-3% of children1; the most 
prevalent age group is in pre-school age children 
between 3 and 5 years. The most common com-
plaints are snoring and difficulty to breath during 
sleep; some children may also present difficult 
and noisy breathing during the day.
The etiology of pediatric OSAS is multifacto-
rial and is specially associated to adenotonsillar 
hypertrophy. Actually, tonsillectomy with ade-
noidectomy (adenotonsillectomy) is the first treat-
ment line in many pediatric OSAS patients6.
Erickson et al7 investigated epidemiological 
trends in tonsillectomy and adenotonsillectomy 
and reported that the indication to perform a ton-
sillectomy and adenotonsillectomy have sub-
stantially shifted in the last years: whereas in 
1970 infections represented the main indication 
for tonsillectomy and adenotonsillectomy (88%), 
today the main indication is a pharyngeal ob-
struction (77%).
Preoperative investigations
The correct identification of OSAS patients 
is important for the anesthesiologist because it 
changes the perioperative and postoperative man-
agement as children with OSAS are at higher risk 
for perioperative airway obstruction8.
Preoperative evaluation of a patient for po-
tential identification of OSAS includes medical 
record review, patient and family interview and 
questionnaires, physical examination, laboratory 
polysomnography (PSG) and home sleep apnea 
testing. The diagnosis has historically been based 
on patient history and physical exam; however, 
it is important to underline that the hypertrophy 
of tonsils and adenoids is not correlated with the 
severity of OSAS. The in-laboratory PSG is the 
gold standard for the diagnosis of OSAS, but 
guidelines recommend this exam for definitive 
diagnosis only in specific cases. Actually, consid-
ering the cost of in-laboratory PSG and the incon-
venience to the patient and caregiver, this is often 
not a reasonable option. When it is not possible 
to execute PSG, many children with symptoms 
of OSAS go unrecognized and thus may be at 
risk for perioperative respiratory adverse events.
Questionnaires are a simple practical tool to 
identify children with symptoms consistent with 
OSAS and SDB; the most common are the OSA-
189, the Pediatric Sleep Questionnaire Sleep-Re-
lated Breathing Disorder10 and the Snoring, Trou-
ble Breathing, Un-Refreshed scales11. Schnoor et 
al12 reported that the use of three core-questions 
(Does your child regularly snore at night? Does 
your child demonstrate labored breathing during 
sleep? Does your child have breathing pauses 
during sleep?) may facilitate the detection of pe-
Table I. Severity ranking system based on polysomnography.
OSAS = obstructive sleep apnea syndrome
 Apnea- Oxygen
 Hypopnea saturation 
 index nadir
Normal 0-1 > 92
Mild OSA 2-4 
Moderate OSA 5-9 
Severe OSA >10 < 80
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diatric OSAS within the scope of the anesthesia 
survey. Unfortunately, given the subjectivity of 
questionnaires as a form of data collection, they 
failed to reach statistically significant results in 
detecting OSAS. 
History and physical examination aimed to 
investigate typical symptoms such as snoring and 
apneas and excessive daytime sleepiness are cru-
cial in the preoperative investigation; however, 
they have limitations in the ability to determine 
the severity of SDB. Actually, it is important to 
underline that presumptive diagnosis based on 
history and physical exam agrees with objective 
data obtained from PSG in about 30-50% of chil-
dren13 and neither tonsil size nor palate positions 
are reliable indicators of disease severity. Nolan 
et al14 reviewed the biomedical literature for data 
comparing clinical and subjective tonsil size to 
objectively measured OSAS using PSG, and they 
found that the association between subjective pe-
diatric tonsil size and objective OSAS severity is 
weak at best. 
In the last decade, research15,16 efforts have 
been made to identify laboratory biomarkers for 
pediatric OSAS. Gozal et al17 assess that high-sen-
sitivity C-reactive protein are higher in children 
with OSAS, and particularly in those who devel-
op neurocognitive deficits as OSAS in children is 
associated with substantial neurobehavioral and 
cognitive dysfunction. However, more studies 
are needed to demonstrate the clinical utility in 
the use of serum biomarkers as screening tools 
for pediatric OSAS. Laboratory PSG and home 
sleep apnea testing are necessary before surgery. 
The American Academy of Sleep Medicine, the 
American Academy of Otolaryngology – Head 
and Neck Surgery, and the American Academy of 
Pediatrics published the guidelines8 regarding the 
appropriate use of laboratory PSG for the diagno-
sis of OSAS in children. These guidelines recom-
mend performing in-laboratory PSG in patients 
with complex medical conditions such as obesi-
ty, Down syndrome, craniofacial abnormalities, 
neuromuscular disorders, sickle cell disease, or 
mucopolysaccharidoses and in patients for whom 
the diagnosis is unclear or discordant with the 
history or physical exam. Overall, it is estimated 
that only 10% of children undergo a PSG prior 
to adenotonsillectomy for SDB18. Actually, PSG 
is expensive, time consuming, and labor inten-
sive. For this reason, the researchers are studying 
home sleep apnea testing. Some individuals use 
overnight oximetry as a screening tool for OSAS, 
but compared with PSG, it has limited sensitivi-
ty and specificity19. Unattended monitoring with 
4-7 channels (Type three studies) has sparse and 
conflicting data regarding utility in the pediatric 
population20.
Preoperative management
Accessing the operating room is a cause of 
anxiety, especially for young patients and the 
presence of parents during induction of anesthe-
sia may be helpful in reducing patient anxiety.
The anesthesiologists must consider the in-
creased complications expected in OSAS patients 
and anxiolytics and sedatives must be carefully 
administrated in these patients (Table II). Pre-
medication in children is performed with oral 
midazolam (0.5 mg/kg) or clonidine; both drugs 
have been shown to be effective and safe. Dex-
medetomidine and ketamine have also been pro-
posed although the safety of their use in pediatric 
patients with OSAS is still being studied.
Perioperative management
Perioperative respiratory adverse events may 
be more frequent in children with symptoms 
of SDB and OSAS. Although many of these 
events can be easily recognized and treated, some 
can be life-threatening and preventing measures 
must be taken in these patients.
Table II. Anesthesiology complication in OSAS children.
Preoperative Perioperative Postoperative  
• Over sedation • Difficult ventilation • PONV
• Respiratory complications • Difficult intubation • Postoperative bleeding
• Anxiety • Post obstructive pulmonary edema  • Over sedation
  • Inhalation • Pain
  • Reintubation • Respiratory complications
PONV: Postoperative nausea and vomiting.
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Some adverse respiratory events may be 
explained by the intermittent hypoxia occur-
ring in SDB. Breslin et al21 demonstrated that 
chronic intermittent hypoxia increases the re-
spiratory sensitivity of rats to morphine by up-
regulating expression of μ-opioid receptor and 
δ-opioid receptor in the medulla. For this rea-
son, the use of perioperative opioid in children 
with OSAS should be carefully evaluated; the 
American Society of Anesthesiologists updated 
in 2014 the practice guidelines on perioperative 
management of patients with OSAS recom-
mending reducing the dose of opioids used 
during surgery by half22.
Other phases that deserve attention are the 
induction of anesthesia, ventilation, and intuba-
tion. Yang et al23 recently evaluated the method 
and the effect of airway intervention before 
tracheal extubation after anesthesia after tonsil-
lectomy under general anesthesia and adenoid-
ectomy under nasal endoscope in children with 
SDB and reported that both methods are equally 
effective.
Several studies in the literature have shown 
that children with SDB are more likely to have 
a medium or high grade of Cormack-Lehane 
scale and they require more attention during in-
tubation and ventilation. During the induction of 
anesthesia with volatile anesthetics, especially 
during spontaneous breathing, the relaxation of 
musculature can lead to the collapse of the upper 
airways causing a difficult mask ventilation. For 
this reason, it may be preferable to obtain a rapid 
induction with intravenous agents and perform 
a rapid airway intubation. Moreover, specific 
drugs must be avoided during induction; they 
include desflurane, as it can irritate airways, 
and suxamethonium that can cause significant 
side effects such as dysrhythmias, hyperkalae-
mia, sudden unexpected death, muscle pain, 
malignant hyperthermia, masseter spasm and 
prolonged neuromuscular blockade in face of 
cholinesterase deficiency.
Propofol is the most commonly used induction 
agent. During the maintenance phase, propofol 
decreases the incidence of PONV as compared 
to isoflurane; Sevoflurane is the most commonly 
used volatile agent for maintenance.
Postoperative practices
Postoperative practices include postoperative 
analgesia and postoperative care, as well as the 
management of postoperative complications such 
as nausea and vomiting and bleeding.
It is important to monitor postoperative ther-
apy, because postoperative respiratory adverse 
events can be life-threatening. 
Use of opioids following tonsillectomy with 
or without adenoidectomy in OSAS children 
may not be safe. The central nervous system 
depressing effects of codeine or hydrocodone 
and their respectively potent morphine or hy-
dromorphone metabolites can further compro-
mise respiratory drive24. Approximately 8-10% 
of children are slow or non-metabolizers of 
codeine, and no amount of codeine will provide 
adequate analgesia. More concerning, 0.5-2% 
of children are rapid metabolizers, converting 
codeine to morphine and producing a much 
higher blood level of the drug than normally 
expected25. Therefore, it is important to stress 
out that some patients can be rapid metabolizers 
of codeine, which is rapidly transformed into 
morphine, and that children with OSAS have a 
greater sensitivity to morphine for desaturation. 
For these reasons in April 2017, the Food and 
Drug Administration24 placed a restriction on 
the use of codeine and tramadol medication in 
children, elevating the previous “warning” that 
was added in 2013.
Nonsteroidal anti-inflammatory drugs 
(NSAIDs) can be considered as an alternative 
to opioids for postoperative analgesic therapy. 
Even if NSAIDs inhibit platelet aggregation and 
prolong bleeding time, the Cochrane Database 
has determined in 2013 that in the pediatric pop-
ulation there is no increased risk of bleeding in 
the postoperative period25. 
In addition to the administration of NSAIDs in 
the postoperative period, palate injection of ket-
amine has proved useful in reducing pain. Less-
er palatine and glossopharyngeal nerve blocks 
combined with general anesthesia improves the 
operative conditions and provides excellent post-
operative analgesia26.
Postoperative care
Statham et al27 analyzed a sample of 2315 
patients younger than 6 years undergoing ad-
enotonsillectomy; of these, 149 (6.4%) devel-
oped a postoperative respiratory complication. 
The authors noticed that postoperative compli-
cations were more frequent in children younger 
than 3 years compared to children aged 3 to 5 
years. Higher incidence of postoperative com-
plications is also present in children with neu-
romuscular disorders, craniofacial morphology 
alterations, Down’s syndrome or pulmonary 
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disease27,28. Down’s syndrome patients have 
predisposing factors to OSAS including large 
tongue, narrow nasopharynx, hypoplastic man-
dibula, muscular hypotonia, obesity, tracheal 
abnormalities, and lymphoid hyperplasia29. For 
their anatomical features of head and neck 
anatomy, these patients often require an ade-
notonsillectomy29-31.
The majority of children undergoing adenoid-
ectomy and tonsillectomy are discharged the day 
of the surgery. The 2011 Academy of Otolar-
yngology - Head and Neck Surgery guidelines 
suggested inpatient postoperative care for chil-
dren with severe OSAS (AHI ≥10/h), SpO2 nadir 
<80%, and/or age <3. In 2012, the American 
Academy of Pediatrics also published guidelines8 
recommending postoperative admission for chil-
dren with OSAS aged <3 years, obese, or with 
SpO2 nadir <80%, or peak PCO2 ≥60 mm Hg. 
While the American Society of Anesthesiologists 
did not issue specific guidelines for postoperative 
admission for children with OSAS, it recom-
mended monitoring these patients until they can 
maintain their oxygen saturation on room air at 
rest, and preferably while sleeping22.
Children with severe OSAS and those with 
comorbidities may also require postoperative in-
tensive care unit admission.
Postoperative nausea 
and vomiting 
A major problem in pediatric patients under-
going tonsillectomy and adenotonsillectomy is 
the high incidence of PONV. Antiemetic drugs 
can reduce PONV; however, their use is not 
always safe. The combination of paracetamol, 
NSAIDs, and fentanyl provide excellent analgesia 
with minimal PONV after elective tonsillectomy 
and adenotonsillectomy32. 
Dexamethasone is widely used to prevent 
PONV in pediatric tonsillectomy. In one study 
from Czarnetzki et al33 the use of high doses of 
dexamethasone was associated to bleeding after 
tonsillectomy; however, high doses were not re-
quired to produce an anti-emetic effect. Accord-
ing to recent studies, dexamethasone could also 
have an analgesic effect although further research 
is needed.
Post-tonsillectomy bleeding 
Post-tonsillectomy bleeding is an emergency 
and can lead to rapid deterioration of hemody-
namics34,35. The incidence of bleeding following 
tonsillectomy is 0.5-2% depending on the surgi-
cal technique and may have serious complications 
including death34,35. The bleeding is most likely to 
occur within the first 24 hours after surgery and 
6-10 days after tonsillectomy. The main factors 
to be considered in post-tonsillectomy bleeding 
are potential hypovolemic shock, pulmonary as-
piration, and potential difficult intubation due to 
bleeding obscuring the view and oedema from 
the previous surgery3,36.
Most clinicians perform preoperative investi-
gations such as clotting profile, full blood count, 
grouping and cross-matching of blood, to reduce the 
incidence of bleeding during and after tonsillecto-
my. However, although these exams may be useful 
in patients who have a history suggestive of a major 
bleeding disorder, routine preoperative coagulation 
studies are not recommended in all patients37,38.
Discussion
Children with OSAS are at higher risk for 
perioperative airway obstruction; therefore, the 
correct identification of OSAS patients is import-
ant for the anesthesiologist because it changes 
the perioperative and post-operative management. 
Preoperative evaluation of a patient for potential 
identification of OSAS includes medical record 
review, patient and family interview and question-
naires, physical examination, laboratory PSG and 
home sleep apnea testing. The in-laboratory PSG 
is the gold standard for the diagnosis of OSAS, 
but guidelines recommend this exam for definitive 
diagnosis only in specific cases; however, when it 
is not possible to execute PSG, many children with 
OSAS are unrecognized and may be at risk for 
perioperative respiratory adverse events.
Preoperative management is mainly aimed at 
reducing anxiety and agitation and is often per-
formed using oral midazolam.
Perioperative respiratory adverse events are 
more frequent in children with OSAS and some 
of these events can be life-threatening. The use 
of perioperative opioid in children with OSAS 
should be carefully evaluated as chronic inter-
mittent hypoxia, typical in patients with SDB, 
upregulates the expression of opioid receptors 
and therefore increases the effects of these drugs. 
Other phases that deserve attention are the in-
duction of anesthesia, ventilation and intubation, 
as the relaxation of musculature can lead to the 
collapse of the upper airways causing a difficult 
mask ventilation.
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It is important to monitor postoperative ther-
apy especially in children with OSAS, because 
postoperative respiratory adverse events can be 
life-threatening. The use of opioids in OSAS 
children is not safe as they can have a stronger 
depressing effect on the central nervous system. 
NSAIDs are instead recommended to control 
postoperative paid. 
A major problem in pediatric patients under-
going tonsillectomy and adenotonsillectomy is 
the high incidence of PONV; dexamethasone is 
currently used to prevent this complication and 
may have a significant role especially in children 
with SDB and OSAS.
Post-tonsillectomy bleeding is an emergency 
and could lead to rapid death34,35,36. Unfortunately, 
preoperative coagulation studies in all pediat-
ric patients undergoing tonsillectomy have not 
shown to be cost-effective and their role seems 
to be limited to patients who have a history sug-
gestive of a major bleeding disorder. 
Further studies to understand preoperatively 
potential indicators of higher risk of post-ton-
sillectomy complications are necessary. Sev-
eral studies have identified age, comorbidities, 
opioid doses, severe OSAS and obesity as risk 
factors for postoperative complications after 
tonsillectomy. In a recent paper from Jaryszak 
et al39, the authors attempted to use preoperative 
PSG to identify risk factors for postoperative 
respiratory complications in pediatric patients 
undergoing tonsillectomy. Data revealed that 
patients who suffered a postoperative respirato-
ry complication had the following risk factors: 
BMI greater than 95%, >30 AHI, 22.6 hypopnea 
index and a nadir oxygen saturation of 74%39. 
Further research is necessary to identify patients 
preoperatively at risk of developing postoper-
ative complications. PSG in the preoperative 
period may be a useful tool to help identify 
these patients. 
Conclusions
OSAS in children is a distinct disorder from 
the condition that occurs in adults, and adenoid-
ectomy and tonsillectomy are the first line of 
therapy in many of these patients. The anesthesi-
ologist must be able to recognize preoperatively 
children affected by OSAS and to manage pos-
sible complications. Therefore, the role of the 
anesthesiologist is children with OSAS is crucial 
before, during and after surgery, as pediatric pa-
tients are at higher risk of preoperative, perioper-
ative and postoperative adverse events including 
airway obstruction, PONV, and bleeding.
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